Abciximab is a monoclonal antibody used as an antiplatelet drug to prevent blood clots during certain cardiovascular procedures. It is administered intravenously and targets glycoprotein IIb/IIIa receptors on platelets to inhibit aggregation. The term denotes a pharmacological agent rather than a general chemical compound, and its pronunciation is pivotal for clear communication in medical settings.
Full pronunciation guide
